CME

Guest: David P. Hudesman, MD Please note: This activity is no longer available for continuing education credit. It is estimated that only 20% to 30% of patients with Crohn’s disease (CD) have a non-progressive or indolent course. While most patients with CD present with non-penetrating or non-stricturing disease, 50% of patients develop intestinal complications within 20 years of diagnosis. In thi...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel disc...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases.

Host: Joseph K. Han, MD Please note: This activity is no longer available for continuing education credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and negatively impacts quality of life. The good news is that biologic therapies targeting type 2 inflammatory pathways provide additional treatment options for CRSwNP. However, clinicians not only need...

Host: Anne O'Donnell, MD Guest: Robert "Brinkley" Sewell Please note: This activity is no longer available for continuing education credit. The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors undersco...

Host: Anne O'Donnell, MD Guest: Patrick Flume, MD Please note: This activity is no longer available for continuing education credit. Nontuberculous mycobacteria lung disease (NTM-LD) is a relatively uncommon condition, although its prevalence is rising. In this interactive CME activity, Drs. Anne O’Donnell and Patrick Flume review two patient cases to demonstrate how clinicians can maintain a...

Host: Peter A. Lio, MD Guest: Eric Simpson, MD, MCR Guest: Mark Boguniewicz, MD Please note: This activity is no longer available for continuing education credit. “I begged my doctor for something else – there had to be something else,” Pam. For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the co...

Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the diagnosis of and treatment approach for interstitial pneumonia with autoimmune features (IPAF).

Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the challenges associated with progressive-fibrosing ILD diagnosis, explains management differences for connective tissue disease-associated ILD, and reviews therapeu...

Host: Eric H. Kraut, MD Hemophilia A is a rare bleeding disorder caused by deficiency of clotting factor VIII. The current standard of care for patients with severe hemophilia A centers on replacement therapy with factor VIII concentrate, either on demand when bleeding occurs or prophylactically (replacement therapy). Potential complications from replacement therapy include the development of inhi...

Host: Leora Horn, MD, MSc Please note: This activity is no longer available for continuing education credit. Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive disease with a poor prognosis. The recent addition of immunotherapy to the treatment landscape has changed the standard of care for ES-SCLC. In this interactive activity an expert will guide you through the latest evidence on...

Host: Patricia K. Coyle, MD Guest: Clyde E. Markowitz, MD Please note: This activity is no longer available for continuing education credit. Multiple sclerosis (MS) is one of the leading causes of disability worldwide . As the treatment armamentarium continues to grow, patient involvement in the development of an effective treatment strategy is becoming increasingly important. In this Clinical Exc...

Guest: Robert A. Baldor, MD Guest: Chadwick R. Johr, MD This innovative, 45-minute, case-based CME activity features two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. Using case studies, the faculty will explore diagnosis and management strategies to maximize patient care. In addition to the analysis of AI cases, key topics will...

Guest: Robert A. Baldor, MD Guest: Chadwick R. Johr, MD This innovative, 30-minute, online activity features a Video Expert Dialogue with two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. The emphasis is on the unique role primary care providers play in diagnosing and managing AI and maximizing patient care. Topics include: Over...

Host: Jennifer Caudle, DO Guest: Thomas C. Wright, Jr., MD The Cervical Cancer Screening practice environment continues to change for both physicians and patients. Physicians are constantly tasked with evaluating analyses of new data on how best to approach cervical cancer screening for a particular patient demographic; and patients remain confused and unsure if the “new” approaches are better, or...

Guest: David S. Friedman, MD, PhD, MPH Guest: Steven J. Gedde, MD Guest: W. Daniel Stamer, PhD THIS ACTIVITY IS NO LONGER AVAILABLE FOR CREDIT. Glaucoma is the leading cause of irreversible vision loss worldwide and it is expected that the number of people affected by glaucoma will increase dramatically in coming decades due to the aging of the world’s population. Despite advances in ocular imagin...

Guest: Sandro Esteves, MD, PhD Recent studies have highlighted limitations of the existing definitions of poor ovarian response. In this video, Dr. Sandro Esteves will review these limitations, explain the new POSEIDON criteria, discuss its new marker of success in Assisted Reproductive Technology, and provide innovative alternatives for clinical management.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In Augus...

Host: Randall Wong, MD Host: Russell Faust, MD Want to speed up your site? Want to improve your SEO? These WordPress plugins can improve your website download speed, a crucial variable in the SEO equation. Making your website faster and improving your SEO will help you get the high rankings you want. And don’t let the technical jargon scare you. If Russ and Randy can use these plugins, so can you!...

Host: Shira Johnson, MD Guest: Jean Bennett, MD, PhD There are 39 million people worldwide who are in total blindness and another 246 million with very low vision. The most frequent forms of visual impairment are caused by problems that can be corrected. Dr. Shira Johnson welcomes Dr. Jean Bennett, Professor of Ophthalmology and Cell and Developmental Biology at the University of Pennsylvania and...

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA,Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC, Mehta A, Kroemer G, Maiuri L, Raia V. Cell Death...

Microbial colonization and lung function in adolescents with cystic fibrosis. Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D. J Cyst Fibros. 2016 May;15(3):340-9. doi: 10.1016/j.jcf.2016.01.004. Epub 2016 Feb 5. Abstract With intensified antibiotic therapy and longer surviva...

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients. Flume PA, VanDevanter DR, Morgan EE, Dudley MN, Loutit JS, Bell SC, Kerem E, Fischer R, Smyth AR, Aaron SD, Conrad D, Geller DE,Elborn JS. J Cyst Fibros. 2016 Jul;15(4):495-502. doi: 10.1016...

Host: Patrice L Basanta-Henry, MD, MHSc, FACOG Egg freezing, or oocyte cryopreservation, can be a major relief for women who wish to preserve their fertility, allowing patients to wait for the “right time.” What are the latest advances in technology and protocol for this procedure, and who are the right patients? Host Dr. Patrice Basanta Henry welcomes guest expert Dr Kenan Omurtag to address thes...